Related Experiment Videos
Multidrug resistance in breast cancer--is the jury in yet?
Journal of the National Cancer Institute
|July 2, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A decade of clinical development of PARP inhibitors in perspective.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Clinical Outcome of Patients with Advanced Biliary Tract Cancer in a Dedicated Phase I Unit.
Clinical oncology (Royal College of Radiologists (Great Britain))·2017
The Influence of Donor and Recipient Gender Incompatibility on Corneal Transplant Rejection and Failure.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Progress in the treatment of ovarian cancer-lessons from homologous recombination deficiency-the first 10 years.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Per- and polyfluoroalkyl substances levels other than PFOS, PFOA, or PFHxS and liver cancer risk: a nested case-control analysis.
Journal of the National Cancer Institute·2026
Effectiveness of an eHealth intervention to improve quality of life in long-term breast cancer survivors: a 9-month randomized controlled trial.
Journal of the National Cancer Institute·2026
Antidepressant and antipsychotic prescriptions among 21 605 English survivors of childhood cancer: a population-based cohort.
Journal of the National Cancer Institute·2026
Recent advancements in gynecologic cancer research: a SPORE investigators meeting report.
Journal of the National Cancer Institute·2026
Breast cancer overdiagnosis in mammography trials-separating signal from noise: a meta-analysis.
Journal of the National Cancer Institute·2026
Expansion of the world health organization (WHO) gastric neuroendocrine tumor classification: introducing types 4 and 5.
Journal of the National Cancer Institute·2026
Safety and Efficacy of Ceralasertib plus Olaparib for Advanced/Metastatic Triple-Negative Breast Cancer in Three Molecular Strata: The Phase II VIOLETTE Study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Fruquintinib: Mechanism of Action, Clinical, and Translational Science.
Clinical and translational science·2026
In the wisdom of Odin: modular architecture, receptor trafficking and therapeutic implications.
Expert opinion on therapeutic targets·2026